Ocean Biomedical, Inc. (OCEA)
NASDAQ: OCEA · Real-Time Price · USD
0.664
+0.075 (12.75%)
At close: Dec 20, 2024, 4:00 PM
0.619
-0.045 (-6.73%)
After-hours: Dec 20, 2024, 7:40 PM EST
Ocean Biomedical Employees
Ocean Biomedical had 9 employees as of December 31, 2021. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$12,718,444
Market Cap
23.12M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 9 | 1 | 12.50% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bionano Genomics | 344 |
| Affimed | 76 |
| Athira Pharma | 67 |
| NKGen Biotech | 63 |
| VSee Health | 40 |
| American Shared Hospital Services | 31 |
| MiNK Therapeutics | 31 |
| Citius Pharmaceuticals | 22 |
OCEA News
- 4 weeks ago - Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewsWire
- 2 months ago - Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter - GlobeNewsWire
- 2 months ago - Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors. - GlobeNewsWire
- 2 months ago - Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses - GlobeNewsWire
- 4 months ago - Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company's Malaria Treatment and Prevention Platforms - GlobeNewsWire
- 7 months ago - Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 - GlobeNewsWire
- 7 months ago - Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease - GlobeNewsWire
- 8 months ago - Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K - GlobeNewsWire